The passage below is from a Cbio statement on 12 Oct 2011:
"The delivery of the final report and completed workplan to Novo Nordisk will trigger an immediate positive Cbio balance sheet change. A US$3 million option fee already recieved from Novo Nordisk has up until now been accounted for an unearned income (and a liability). however this amount will now be earned by Cbio and considered income in the current financial year."
I didn't notice any mention of it in the recent appendix 4C
Correct me if I'm wrong....
CBZ Price at posting:
8.7¢ Sentiment: Hold Disclosure: Held
HotCopper & The Market Online will be live From the Floor at the Mining News Select Conference and we want to bring the voice of our online audience to the show with us.